Compare Bio Protocol (BIO) vs Brevis (BREV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Brevis — how do they compare? Bio Protocol trades at Rp513.64 (market cap Rp1,16T, Rp252,63M 24h volume), while Brevis trades at Rp1,329 (market cap Rp331,92M, Rp229,7M 24h volume). The key difference: Bio Protocol is far larger — about 3494.8× Brevis's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 250M / 1B BREV (25%) for Brevis. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Brevis for 6 Days on average.
| BIO | BREV | |
|---|---|---|
Market Cap | Rp1,16T | Rp331,92M |
Volume (24h) | Rp252,63M | Rp229,7M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 250M / 1B BREV (25%) |
Typical Hold Time | 16 Days | 6 Days |
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Brevis
Brevis is a verifiable computing platform that enables scalable, trustless computation across blockchain, data, and AI systems. It allows complex programs and data queries to run off-chain and be verified on-chain using zero-knowledge proofs, delivering significantly lower costs and latency while preserving security and trustlessness.
Read more on BREV →
